Bristol-Myers Squibb Co (BMY)

Common Stock

Sell: $58.15|Buy: $58.25|Change: 1.26 (-2.12%)

Open

$59.155

Previous close

$59.37

Trade high

$59.64

Volume

12,850,610

Year high

$62.8864

Year low

$42.52

Dividend yield

4.19%

Market capitalisation

$118.34 bn

P/E ratio

17.16

ISIN

US1101221083

This share can be held in a Dealing account Stocks and shares ISA Lifetime ISA JISA SIPP

Share price

Dividends

	Previous	Latest
Record date	02/01/2026	02/04/2026
Ex-dividend date	02/01/2026	02/04/2026
Payment date	02/02/2026	01/05/2026
Amount	$0.63	$0.63

Performance 19/03/2026

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann

	Total return (%)
Bristol-Myers Squibb Co	- 2.12
More...

Company profile

Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

Sector

Healthcare

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.